Oncology Institute, Inc.

**Signal Note: Deerfield Initiates $12.1M Position in Oncology Institute** Deerfield's entry into TOIIW suggests conviction in the company's oncology service delivery model or pipeline assets, though the position size ($12.1M) is modest relative to typical healthcare multi-strategy deployments. Without visibility into specific clinical catalysts or asset-level drivers, this appears to be a foundational position that may expand pending upcoming trial readouts or operational inflection points.